Brigitte Rack

17.4k total citations · 2 hit papers
218 papers, 6.6k citations indexed

About

Brigitte Rack is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brigitte Rack has authored 218 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Oncology, 123 papers in Cancer Research and 62 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brigitte Rack's work include Cancer Cells and Metastasis (94 papers), Breast Cancer Treatment Studies (65 papers) and Cancer Genomics and Diagnostics (56 papers). Brigitte Rack is often cited by papers focused on Cancer Cells and Metastasis (94 papers), Breast Cancer Treatment Studies (65 papers) and Cancer Genomics and Diagnostics (56 papers). Brigitte Rack collaborates with scholars based in Germany, Austria and United States. Brigitte Rack's co-authors include Wolfgang Janni, Klaus Pantel, Christian Schindlbeck, Volkmar Müller, Tanja Fehm, Sabine Riethdorf, Klaus Friese, Thomas W. P. Friedl, Peter A. Fasching and Ulrich Andergassen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Brigitte Rack

205 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

2007 1.1k citations Sabine Riethdorf, Volkmar Müller et al. Clinical Cancer Research profile →
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

2014 472 citations Brigitte Rack, Christian Schindlbeck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brigitte Rack Germany	37	4.6k	3.7k	1.9k	1.5k	784	218	6.6k
Michail Ignatiadis Belgium	40	3.8k 0.8×	3.8k 1.0×	2.3k 1.2×	1.5k 1.0×	467 0.6×	128	6.6k
Peter Vermeulen Belgium	42	3.2k 0.7×	2.7k 0.7×	3.1k 1.6×	1.1k 0.7×	361 0.5×	142	6.6k
Edwin M. Posadas United States	41	1.9k 0.4×	1.9k 0.5×	2.7k 1.4×	1.9k 1.2×	611 0.8×	173	5.6k
Marius Ilié France	42	3.3k 0.7×	2.4k 0.6×	1.8k 0.9×	2.3k 1.5×	338 0.4×	165	5.9k
Wolfgang Janni Germany	44	6.7k 1.5×	5.3k 1.5×	2.3k 1.2×	2.5k 1.6×	868 1.1×	396	10.2k
Steven J. Cohen United States	40	5.0k 1.1×	2.1k 0.6×	1.2k 0.6×	1.8k 1.2×	631 0.8×	174	6.6k
Joel W. Neal United States	37	4.0k 0.9×	2.8k 0.8×	2.6k 1.4×	3.7k 2.4×	318 0.4×	259	7.8k
Matthew Krebs United Kingdom	28	4.0k 0.9×	2.2k 0.6×	1.4k 0.8×	1.9k 1.2×	796 1.0×	156	5.4k
Mustafa Khasraw Australia	34	2.3k 0.5×	1.3k 0.3×	1.7k 0.9×	1.5k 1.0×	570 0.7×	194	5.8k
Marija Balić Austria	30	2.5k 0.6×	1.6k 0.4×	1.0k 0.5×	737 0.5×	834 1.1×	123	3.8k

Countries citing papers authored by Brigitte Rack

Since Specialization

Citations

This map shows the geographic impact of Brigitte Rack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Rack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Rack more than expected).

Fields of papers citing papers by Brigitte Rack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Rack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Rack. The network helps show where Brigitte Rack may publish in the future.

Co-authorship network of co-authors of Brigitte Rack

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Rack. A scholar is included among the top collaborators of Brigitte Rack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Rack. Brigitte Rack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pfister, Kerstin, Elena Leinert, Brigitte Rack, et al.. (2025). Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib – Which One, How and For Whom?. Geburtshilfe und Frauenheilkunde. 85(6). 590–598.

Dannehl, Dominik, Kerstin Pfister, Brigitte Rack, et al.. (2024). Abstract PO5-16-11: Novel antibody-drug-conjugates in clinical routine: adherence, efficacy and tolerability - real-world data from German breast centers. Cancer Research. 84(9_Supplement). PO5–16.

Günther, Julia, Dorothy Meyer, Joachim Hermsdörfer, et al.. (2024). Effect of a comprehensive lifestyle intervention program on body weight and health behavior in women with breast cancer: Results from a randomized controlled trial. Clinical Nutrition. 43(9). 1937–1951. 6 indexed citations

Gregorio, Amelie de, Wolfgang Janni, Thomas W. P. Friedl, et al.. (2022). The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C. British Journal of Cancer. 126(12). 1715–1724. 23 indexed citations

Banys-Paluchowski, Malgorzata, Isabell Witzel, Bahriye Aktas, et al.. (2019). The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. Scientific Reports. 9(1). 2318–2318. 27 indexed citations

Zeune, Leonie L., Guus van Dalum, Charles Decraene, et al.. (2017). Quantifying HER-2 expression on circulating tumor cells by ACCEPT. PLoS ONE. 12(10). e0186562–e0186562. 32 indexed citations

Janni, Wolfgang, Brigitte Rack, Leon W.M.M. Terstappen, et al.. (2016). Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clinical Cancer Research. 22(10). 2583–2593. 265 indexed citations

Jueckstock, J, Brigitte Rack, Thomas W. P. Friedl, et al.. (2016). Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial. BMC Cancer. 16(1). 401–401. 14 indexed citations

Friedl, Thomas W. P., Fabienne Schochter, Christoph Scholz, et al.. (2015). Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program. Archives of Gynecology and Obstetrics. 293(2). 271–281. 40 indexed citations

10.

Andergassen, Ulrich, Alexandra C. Kölbl, Christian Schindlbeck, et al.. (2013). Detection of Breast Cancer Cells in Blood Samples by Immunostaining of the Thomsen–Friedenreich Antigen. Future Oncology. 9(5). 747–752. 2 indexed citations

11.

Rack, Brigitte, et al.. (2012). Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients.. PubMed. 27(7). 855–64. 12 indexed citations

12.

Schwarzenbach, Heidi, et al.. (2012). Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression. Clinical Cancer Research. 18(20). 5719–5730. 50 indexed citations

13.

Janni, Wolfgang, Florian D. Vogl, Gro Wiedswang, et al.. (2011). Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis. Clinical Cancer Research. 17(9). 2967–2976. 192 indexed citations

14.

Rack, Brigitte, et al.. (2011). Ultrasound for the assessment of bone quality in preterm and term infants. Journal of Perinatology. 32(3). 218–226. 43 indexed citations

15.

Janni, Wolfgang, Philip Hepp, Carolin Nestle-Kraemling, et al.. (2009). Treatment of pregnancy-associated breast cancer. Expert Opinion on Pharmacotherapy. 10(14). 2259–2267. 6 indexed citations

16.

Rack, Brigitte, et al.. (2008). Mit Biologicals näher am Ziel. MMW - Fortschritte der Medizin. 150(1-2). 34–36. 1 indexed citations

17.

Janni, W, Nadia Harbeck, Brigitte Rack, et al.. (2007). Final toxicity analysis of the ADEBAR phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement. mediaTUM (Technical University of Munich). 1 indexed citations

18.

Kiewe, Philipp, Stephan Hasmüller, Steffen Kahlert, et al.. (2006). Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer. Clinical Cancer Research. 12(10). 3085–3091. 139 indexed citations

19.

Rack, Brigitte, Bernd Gerber, Ingo Bauerfeind, et al.. (2006). Pregnancy-Associated Breast Cancer – Special Features in Diagnosis and Treatment. Oncology Research and Treatment. 29(3). 107–112. 5 indexed citations

20.

Schindlbeck, Christian, W Janni, Brigitte Rack, et al.. (2005). Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?. Journal of Cancer Research and Clinical Oncology. 131(8). 539–546. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact